Abstract
Although oxidative stress and mitochondrial dysfunction have been linked to neurodegenerative diseases such as Alzheimers disease (AD), it remains unclear how mitochondrial oxidative stress may induce neuronal death. In a variety of tissues, cumulative oxidative stress, disrupted mitochondrial respiration, and mitochondrial damage are associated with, and may indeed promote cell death and degeneration. In this review, we examine current evidence supporting the involvement of mitochondria and mitochondrially generated stress signaling in AD and discuss potential implications for the mechanism of pathogenesis of this disease. Mitochondria are pivotal in controlling cell life and death not only by producing ATP, and sequestering calcium, but by also generating free radicals and serving as repositories for proteins which regulate the intrinsic apoptotic pathway. Perturbations in the physiological function of mitochondria inevitably disturb cell function, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of a number of neurodegenerative disorders including AD.
Keywords: Alzheimer's disease, oxidative stress, mitochondrial dysfunction, signal transduction, stress activated protein kinases, eactive oxygen species, presenilin, amyloid precursor protein, cybrids, apoptosis
Current Alzheimer Research
Title: Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease
Volume: 3 Issue: 4
Author(s): Isaac G. Onyango and Shaharyar M. Khan
Affiliation:
Keywords: Alzheimer's disease, oxidative stress, mitochondrial dysfunction, signal transduction, stress activated protein kinases, eactive oxygen species, presenilin, amyloid precursor protein, cybrids, apoptosis
Abstract: Although oxidative stress and mitochondrial dysfunction have been linked to neurodegenerative diseases such as Alzheimers disease (AD), it remains unclear how mitochondrial oxidative stress may induce neuronal death. In a variety of tissues, cumulative oxidative stress, disrupted mitochondrial respiration, and mitochondrial damage are associated with, and may indeed promote cell death and degeneration. In this review, we examine current evidence supporting the involvement of mitochondria and mitochondrially generated stress signaling in AD and discuss potential implications for the mechanism of pathogenesis of this disease. Mitochondria are pivotal in controlling cell life and death not only by producing ATP, and sequestering calcium, but by also generating free radicals and serving as repositories for proteins which regulate the intrinsic apoptotic pathway. Perturbations in the physiological function of mitochondria inevitably disturb cell function, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of a number of neurodegenerative disorders including AD.
Export Options
About this article
Cite this article as:
Onyango G. Isaac and Khan M. Shaharyar, Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease, Current Alzheimer Research 2006; 3 (4) . https://dx.doi.org/10.2174/156720506778249489
DOI https://dx.doi.org/10.2174/156720506778249489 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Dynamics Simulations of Intrinsically Disordered Proteins in Human Diseases
Current Computer-Aided Drug Design Genetic Variants and Oxidative Stress in Alzheimer’s Disease
Current Alzheimer Research Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold
Current Neuropharmacology Group I Metabotropic Glutamate Receptor Interacting Proteins: Fine-Tuning Receptor Functions in Health and Disease
Current Neuropharmacology The MT2 Melatonin Receptor Subtype is Present in Human Retina and Decreases in Alzheimers Disease
Current Alzheimer Research Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
Current Neuropharmacology Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders
Mini-Reviews in Medicinal Chemistry Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Current Gene Therapy Naturally Inspired Pyrimidines Analogues for Alzheimer’s Disease
Current Neuropharmacology Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience Antioxidants in the Practice of Medicine; What Should the Clinician Know?
Cardiovascular & Hematological Disorders-Drug Targets Cannabinoids and Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Neuroprotection by Resveratrol in Diabetic Neuropathy: Concepts & Mechanisms
Current Medicinal Chemistry Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Current Alzheimer Research Electrochemical Sensors for Hydroperoxides Based on Prussian Blue
Current Analytical Chemistry Cholesterol in Alzheimers Disease: Unresolved Questions
Current Alzheimer Research The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia
Current Pharmaceutical Design Editorial (Thematic Issue: Neuroprotective Effects of Li - It is Elementary)
Current Alzheimer Research The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders
Mini-Reviews in Medicinal Chemistry Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued)